Partners Investment

Partners Investment, established in 2000 and headquartered in Seoul, South Korea, is an investment company that focuses on providing long-term support and constructive contributions to its portfolio companies. Specializing in buyouts and startup investments in various sectors including information technology, biotechnology, digital contents, healthcare, and more, Partners Investment aims to promote ventures and facilitate foreign technology placement. With a strategic focus on regions like Seoul, Incheon, Gyeonggi, Gangwon, and Chungnam, the firm also considers secondary investments to support its investment objectives.

Jaeyeol An

Director

Jong-soo Cho

MD

Joon-young Kil

Investment Professional

Hyuncheol Kim

MD

Hyunchul Kim

MD

Jaewan Kim

CEO

Minsung Kim

Director

Yongha Kim

MD

Chikeun Lee

Director

Jang-hee Lee

Director

Suwoong Park

Director

Soojin Park

Director

Seo CPA, Joonhwan

MD

Soomin Shim

MD

Soomin Sim

MD

Je-in Yoo

Director

95 past transactions

Okxe

Series A in 2020
OKXE VIETNAM COMPANY LIMITED operates an online e-commerce platform for motorbikes. The platform enables users to buy and sell motorcycles online. The company was founded in 2018 and is based in Hanoi, Vietnam.

Senda Biosciences

Series B in 2021
Senda Biosciences is pioneering the field of Intersystems Biology to create novel treatments for human disease. Intersystems Biology focuses on how molecular connections between botanical, bacterial, and human cells—coevolved over millennia—define health and disease. Senda's Intersytems Biology discovery platform, built using new techniques in machine learning and computational biology, has been able to generate novel, actionable insights into the trillions of interspecies molecular connections in the human body, and harnesses the power of this "pharmacy within us" with novel pharmacological approaches. The power of the Senda platform is illustrated by six preclinical programs in oncology, neurology, chronic disease, and metabolic disease.

Astrogen Co.,Ltd.

Private Placement in 2020
Astrogen Co.,Ltd. develops, manufactures, and distributes drugs for the treatment of intractable neurological diseases. The company’s products helps in preventing and treating metabolic diseases by improving cognition, antidiabetic, antioxidant, and antithrombotic activity. The company was founded in 2017 and is based in Daegu, South Korea.

z-emotion

Venture Round in 2019
We are building a fully connected 3D design platform that is at the heart of the digital supply chain of the future and provides predictive big data analytics in value chain in fashion industry.

EJN

Series A in 2020
EJN Corp. owns and operates online community platforms and services for gamers. The company offers e-sports platform Battle.dog, which analyzes the viewing data of e-sports competitions; and Twip an online sales channel for creators and streamers; and Twitch, an online social community for games. It also offers community and payment services for game video streaming services. EJN Corp. was incorporated in 2016 and is based in Seoul, South Korea.

CHATIE

Venture Round in 2020
Eineblume Co., Ltd designs and develops Chatie application through which users can chat with each other. The company is based in Seoul, South Korea.

OGQ

Series B in 2021
Social Creators Platform. Creators meet their fans and sell own works in OGQ market. 14M creators including photographer, videoist, musician, illustrator and font-creator. 30% Users are comprised of US, India and Russia mainly. All images, videos, musics like BGM, stickers and fonts are provided to Messengers, Search and Portal platforms globally. 240M app downloaded, 2.6B contents downloaded, 4.6 rating in Google Play, 30 languages applied.

MAXST

Series B in 2019
MAXST Co., Ltd. designs and develops augmented reality software development kit. The company's MAXST AR SDK, an augmented reality software development kit, is a cross-platform augmented reality engine that provides features and environment to develop augmented reality applications. The company's platform provides remote communication and collaboration services. The company was founded in 2010 and is based in Seoul, South Korea.

Riiid

Series B in 2018
Established in 2014, Riiid is a global leading AI Tutor solution provider delivering creative disruption to the education market through its cutting-edge AI technology. Having launched Santa TOEIC in 2017, the firm’s first commercialized AI Tutor solution based on deep learning algorithm which has garnered 1 million users solely in Korea market with proven efficacy, Riiid leads the era of AI-based education in true sense. Leveraging the firm’s highly scalable and proven AI solution, Riiid is aggressively expanding its business to new test areas as well as into new geographical markets. It currently operates Santa TOEIC in Japan and has launched Santa SAT in Vietnam. Riiid aims at replacing hard copy textbooks and traditional lectures with AI Tutor. Through the firm's technology, any individual student gains access to a personalized AI tutor that far outpaces human tutors in terms of learning efficacy at a fraction of the cost. Driving the democratization and equalization of educational opportunities, Riiid is transforming learning and the industry landscape in remarkable and rapid fashion.

PinotBio

Series A in 2017
Pinot Bio is a biotechnology company that specializes in developing new generation anticancer treatments.

Ring Therapeutics

Series B in 2021
Ring Therapeutics is a multi-product platform company focused on discovering and developing Anellovector therapeutics to unlock the full potential of gene therapy. Founded by Flagship Pioneering, Ring is pioneering the first redosable and targetable gene therapy platform by harnessing the biology of the human commensal virome. The company is expanding the applications of gene therapy beyond gene replacement, enabling a much wider array of modalities and mechanisms to treat previously inaccessible diseases.

Moai Games

Series A in 2016
Moai Games is an independent games developing compan

ALLO

Seed Round in 2021
BeeCanvas is a developer of a modern visual workspace platform intended to maximize productivity. The company's platform leverages technology to provide a unique collaboration experience using web-based invites and also integrates and shares features with other applications, enabling clients to better collaborate and communicate with their teams.

Rznomics

Series B in 2021
This is a biotechnology company founded by professor Lee Sung-wook's lab They are working on the development of gene therapy products for liver cancer through the development of gene therapy products. It was selected by the TIPS program and was recognized for excellence in technology.

Cerecin

Series A in 2021
Cerecin is a healthcare company that develops novel evidence-based therapeutics and products that aim to help people. We develop novel evidence-based therapeutics and products that aim to help millions of people. These solutions are designed to target conditions ranging from memory impairment to Alzheimer’s disease and other devastating neurological diseases.

GeneCast

Series A in 2018
Genecast co., ltd. develops oncology kits. The products include EGFR Mutation Test Kit, BRAF Mutation Test Kit, and JAK2 Mutation Test Kit. The company was founded in 2016 and is based in Seoul, South Korea.

AffaMed Therapeutics

Series B in 2021
AffaMed Therapeutics is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products.

Bionetix Therapeutics

Venture Round in 2017
Bionetix Therapeutics is a developer of anticancer drugs designed for cancer treatment. The company's drugs include medicines for ophthalmic disease and glaucoma treatment, enabling patients to get early treatment for eye diseases, cancer and other diseases with unmet needs.

Remember

Venture Round in 2015
Remember is the number one business card management application in Korea that secretary inputs directly when you take a business card.

SMATOOS Japan

Venture Round in 2015
SMATOOS is a global educational technology company with current branches in Seoul.

Infit & Company Inc.

Series A in 2018
Infit & Company Inc. is a manufacturer of medical diagnostic devices and wellness devices that targeting global healthcare industry.

AmazeVR

Series A in 2020
AmazeVR is a virtual concert platform for the highest quality VR content creation and mass distribution. We're providing an end-to-end solution for a radical new way to experience immersive music content with our proprietary technologies—from ultra-high-resolution custom cameras to cloud-based creation tools, to intuitive social interactions with friends as avatars. As we vertically integrate distribution channels, artists will reach a broad audience with AmazeVR through offline distribution (Amaze Tour) complying the COVID-19 safety measures and online distribution (Amaze Music app and other media including YouTube, TikTok, and Twitch). AmazeVR was founded in 2015 by the founders and former executives of Kakao, a $27B market cap mobile platform company.

Cellestia

Series B in 2019
Cellestia Biotech AG, a biopharmaceutical company, engages in the development of anti-cancer drugs that modulate the NOTCH signaling pathway for the treatment of oncology and immunological disorders. The company focuses on developing its lead development candidate CB-103, which is a small molecule drug candidate. Its CB-103 is a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The company also focuses on developing NOTCH-specific PD biomarkers and diagnostics for patient selection. Cellestia Biotech AG was founded in 2014 and is headquartered in Basel, Switzerland with an additional location in Lausanne.

Riiid! Inc.

Private Placement in 2018
Riiid! Inc. develops a learning application platform based on artificial intelligence. The company was founded in 2014 and is based in Seoul, South Korea.

Still8

Series B in 2016
In the early days of E-Sports, unrivaled skills and overflowing enthusiasm towards games were the only two requisites to become a professional gamer. Nowadays with the rise of global E-Sports fandoms, performance became only one of many requisites of a pro-gamer. Fans are connected to pro-gamers everywhere through various channels such as SNS and live & video platforms. In order to satisfy their needs and be loved by them, a professional gamer needs more than just playing games. E-Sportainment is the compound word of E-Sports and Entertainment. It’s the most explicit and mission-oriented word to describe what STILL8 does. Combining entertainment factors with E-Sports, we help current pro-gamers to boost their talents and retired pro-gamers to sustain their career. Playing games is one part, amusing fans with various entertainments is another. As so, STILL8 ultimately pursues the E-Sports of the gamer, by the gamer, and for the gamer.

Knowre

Venture Round in 2014
Knowre is an education technology company delivering personalized and engaging learning experiences to students around the globe. Its technology identifies individual student learning gaps and fills those gaps through algorithmically generated curricula and interactive, scaffolded support. Knowre further enhances learning by providing students with an engaging and fun learning environment, and teachers with actionable and comprehensive data. Knowre partners with schools, private education companies, and other corporations with the goal of helping students reach their full potential. The company was founded in 2012 and is headquartered in New York, New York.

ALLO

Seed Round in 2021
BeeCanvas is a developer of a modern visual workspace platform intended to maximize productivity. The company's platform leverages technology to provide a unique collaboration experience using web-based invites and also integrates and shares features with other applications, enabling clients to better collaborate and communicate with their teams.

Cytonus Therapeutics

Series A in 2023
Cytonus Therapeutics Inc. is a San Diego-based biotech company that has developed a vast platform of proprietary immunotherapeutic products to treat a wide range of medical conditions including cancers, infectious diseases, inflammatory diseases and cognitive disorders, and to improve patient outcomes. Its proprietary Cargocyte™ technologies are next-generation Biomolecular Delivery Transporter™ which have numerous medical applications across unmet therapeutic areas. Cargocytes™ are engineered to safely transport a multiplicity of therapeutic payloads into difficult-to-reach targeted tissues, and can be programmed to deliver selective, potent, and controllable allogeneic therapies.

Yanolja

Series B in 2016
Yanolja is the fastest-growing No.1 OTA, and the only ‘Unicorn’ among travel related companies in South Korea. In the online business, as a ‘Super App’, Yanolja provides all services for travel including accommodation, leisure and transportation. In the offline sector, it is one of the largest franchise operators in Southeast Asia, managing more than 10,000 rooms. It is also Asia’s best full-stack hospitality company, supplying an integrated hotel platform by effectively utilizing IoT, AI and blockchain technologies. Yanolja is now also one of the global Top 2 PMS providers. It has integrated entire hotel operations, covering from front office to back office including housekeeping and maintenance. Yanolja connects the B2B2C value chain of the travel industry with a one-stop network and integrates it into a single platform.

Olive Healthcare

Series B in 2019
Olive Healthcare is a digital healthcare and medical diagnostic devices company. It is focused on abdominal fat scanning and breast cancer diagnosis, using nonradiative and noninvasive near infrared (NIR) technology, artificial intelligence (AI) algorithms, and big data processing for a customized medical service.

Anipen

Convertible Note in 2021
ANIPEN (애니펜) is a Korean 3D content development platform that enables enterprises to develop video communication and entertainment platforms.

Cytonus Therapeutics

Venture Round in 2023
Cytonus Therapeutics Inc. is a San Diego-based biotech company that has developed a vast platform of proprietary immunotherapeutic products to treat a wide range of medical conditions including cancers, infectious diseases, inflammatory diseases and cognitive disorders, and to improve patient outcomes. Its proprietary Cargocyte™ technologies are next-generation Biomolecular Delivery Transporter™ which have numerous medical applications across unmet therapeutic areas. Cargocytes™ are engineered to safely transport a multiplicity of therapeutic payloads into difficult-to-reach targeted tissues, and can be programmed to deliver selective, potent, and controllable allogeneic therapies.

Rznomics

Series C in 2022
This is a biotechnology company founded by professor Lee Sung-wook's lab They are working on the development of gene therapy products for liver cancer through the development of gene therapy products. It was selected by the TIPS program and was recognized for excellence in technology.

Vedanta Biosciences

Series C in 2019
Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing of rationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily. It was founded in 2010 and is headquartered in Cambridge, Massachusetts.

GeneCast

Series B in 2020
Genecast co., ltd. develops oncology kits. The products include EGFR Mutation Test Kit, BRAF Mutation Test Kit, and JAK2 Mutation Test Kit. The company was founded in 2016 and is based in Seoul, South Korea.

Okxe

Series A in 2021
OKXE VIETNAM COMPANY LIMITED operates an online e-commerce platform for motorbikes. The platform enables users to buy and sell motorcycles online. The company was founded in 2018 and is based in Hanoi, Vietnam.

Sharetreats

Series B in 2022
Sharetreats Innovation develops a platform through which consumers can send or receive vouchers which can be then redeemed at select nearest branch. The treat codes are sent via SMS after the payment is done. The company is headquartered in Makati, Philippines.

Sharetreats

Series A in 2019
Sharetreats Innovation develops a platform through which consumers can send or receive vouchers which can be then redeemed at select nearest branch. The treat codes are sent via SMS after the payment is done. The company is headquartered in Makati, Philippines.

AmazeVR

Venture Round in 2022
AmazeVR is a virtual concert platform for the highest quality VR content creation and mass distribution. We're providing an end-to-end solution for a radical new way to experience immersive music content with our proprietary technologies—from ultra-high-resolution custom cameras to cloud-based creation tools, to intuitive social interactions with friends as avatars. As we vertically integrate distribution channels, artists will reach a broad audience with AmazeVR through offline distribution (Amaze Tour) complying the COVID-19 safety measures and online distribution (Amaze Music app and other media including YouTube, TikTok, and Twitch). AmazeVR was founded in 2015 by the founders and former executives of Kakao, a $27B market cap mobile platform company.

Vedanta Biosciences

Series C in 2019
Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing of rationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily. It was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Cellestia

Private Placement in 2019
Cellestia Biotech AG, a biopharmaceutical company, engages in the development of anti-cancer drugs that modulate the NOTCH signaling pathway for the treatment of oncology and immunological disorders. The company focuses on developing its lead development candidate CB-103, which is a small molecule drug candidate. Its CB-103 is a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The company also focuses on developing NOTCH-specific PD biomarkers and diagnostics for patient selection. Cellestia Biotech AG was founded in 2014 and is headquartered in Basel, Switzerland with an additional location in Lausanne.

Phantom AI

Series A in 2020
Phantom AI is democratizing the use of advanced driver assistance systems (ADAS) to reduce accidents, save lives and make driving more enjoyable, while delivering tomorrow’s self-driving technology. The company provides a comprehensive autonomous driving platform featuring computer vision, sensor fusion and control capabilities. Phantom AI has created the most accurate and highest-performing AI solutions available today that meet car manufacturer requirements, at a much lower price than existing solutions. Delivered through a modular, software-based vehicle stack, OEMs and Tier 1 suppliers can select the components they wish to integrate and customize the configuration for unparalleled flexibility.

Astrogen Co.,Ltd.

Private Placement in 2019
Astrogen Co.,Ltd. develops, manufactures, and distributes drugs for the treatment of intractable neurological diseases. The company’s products helps in preventing and treating metabolic diseases by improving cognition, antidiabetic, antioxidant, and antithrombotic activity. The company was founded in 2017 and is based in Daegu, South Korea.

Cytonus Therapeutics

Seed Round in 2022
Cytonus Therapeutics Inc. is a San Diego-based biotech company that has developed a vast platform of proprietary immunotherapeutic products to treat a wide range of medical conditions including cancers, infectious diseases, inflammatory diseases and cognitive disorders, and to improve patient outcomes. Its proprietary Cargocyte™ technologies are next-generation Biomolecular Delivery Transporter™ which have numerous medical applications across unmet therapeutic areas. Cargocytes™ are engineered to safely transport a multiplicity of therapeutic payloads into difficult-to-reach targeted tissues, and can be programmed to deliver selective, potent, and controllable allogeneic therapies.

AmazeVR

Venture Round in 2021
AmazeVR is a virtual concert platform for the highest quality VR content creation and mass distribution. We're providing an end-to-end solution for a radical new way to experience immersive music content with our proprietary technologies—from ultra-high-resolution custom cameras to cloud-based creation tools, to intuitive social interactions with friends as avatars. As we vertically integrate distribution channels, artists will reach a broad audience with AmazeVR through offline distribution (Amaze Tour) complying the COVID-19 safety measures and online distribution (Amaze Music app and other media including YouTube, TikTok, and Twitch). AmazeVR was founded in 2015 by the founders and former executives of Kakao, a $27B market cap mobile platform company.

z-emotion

Series A in 2020
We are building a fully connected 3D design platform that is at the heart of the digital supply chain of the future and provides predictive big data analytics in value chain in fashion industry.

Okxe

Private Placement in 2020
OKXE VIETNAM COMPANY LIMITED operates an online e-commerce platform for motorbikes. The platform enables users to buy and sell motorcycles online. The company was founded in 2018 and is based in Hanoi, Vietnam.

MyMusicTaste

Series A in 2016
MyMusicTaste is a fan initiated live event making service that brings fans, artists and promoters from all over the world together in one place to create a valuable and meaningful concert experience for everyone involved. MyMusicTaste puts the power in the fans' hands, allowing fans to request their favorite artist's concert in their city. Based on this demand, MyMusicTaste provides data-driven insights to artists and concert promoters the ability to organize highly successful concerts around the world. MyMusicTaste is quickly shaping a new paradigm for how concerts and live events are organized.

SMATOOS

Series B in 2015
SMATOOS (스마투스) is a Korean edtech startup that develops educational services including BeNative, BeNative Pro, and CashEnglish. BeNative Pro, launched in 2015, is the #1 English-learning service in Asia. It is currently being used by Samsung, LG, and over 2000 other companies and universities. BeNative, available on both iOS and Android devices, was released in July 2016 as a free download. Users get access to all content for free, while also being rewarded with weekly cash prizes generated from video ads. It's time to be rewarded for learning! The summer of 2016 also saw the release of CashEnglish and CashSpanish. These apps gamify language learning by also rewarding users with cash rewards. No risks involved. Just Play, Learn, Win! SMATOOS is a portmanteau of Koreanized English words meaning to "study smarter."

Yanolja

Venture Round in 2015
Yanolja is the fastest-growing No.1 OTA, and the only ‘Unicorn’ among travel related companies in South Korea. In the online business, as a ‘Super App’, Yanolja provides all services for travel including accommodation, leisure and transportation. In the offline sector, it is one of the largest franchise operators in Southeast Asia, managing more than 10,000 rooms. It is also Asia’s best full-stack hospitality company, supplying an integrated hotel platform by effectively utilizing IoT, AI and blockchain technologies. Yanolja is now also one of the global Top 2 PMS providers. It has integrated entire hotel operations, covering from front office to back office including housekeeping and maintenance. Yanolja connects the B2B2C value chain of the travel industry with a one-stop network and integrates it into a single platform.

WIDER PLANET Inc.

Series C in 2014
WIDER PLANET Inc. operates advertising platforms in South Korea and internationally. Its platforms analyze digital users’ preferences and interests based on big data, and recommends and delivers optimal, targeted marketing, and advertisement contents. The company offers demand side platform that provides information about categorized users to meet the client’s needs; data management platform, a marketing tool to collect and analyze holistic behavioral data of target customers; real-time bidding platform; and SSP advertising tool. It also provides display and mobile advertising services. The company was founded in 2010 and is based in Seoul, South Korea.

Classting

Series A in 2014
Classting aspires to solve one of the most critical problems that have existed for more than a century: A teacher has to teach many students of varying levels in a classroom. We equip teachers with an effective Learning Management System (LMS) tool and a social platform for classrooms to facilitate communication among teachers, students, and parents. We also offer an AI-based learning platform that provides a personalized learning experience to students in- and outside of the school. Partnering with 20+ content providers, we are helping students all over the world to learn more effectively and efficiently. Classting is based in Seoul.

Bagelcode

Private Placement in 2020
Bagelcode, Inc. develops and operates mobile gaming applications. It provides mobile social casinos. The company was founded in 2012 and is based in Seoul, South Korea.

Linewalks

Series A in 2020
Provider of in-depth data analysis services intended to discover infinite value by utilizing various healthcare big data. The company's artificial intelligence software discovers clinical evidence by analyzing real-world data (RWD) generated in actual treatment sites, monitors the treatment path of patients with cardiovascular disease, and analyzes individual risk, enabling pharmaceutical companies and domestic hospitals to uncover important insights and save time.

Olive Healthcare

Series A in 2018
Olive Healthcare is a digital healthcare and medical diagnostic devices company. It is focused on abdominal fat scanning and breast cancer diagnosis, using nonradiative and noninvasive near infrared (NIR) technology, artificial intelligence (AI) algorithms, and big data processing for a customized medical service.

AmazeVR

Series B in 2021
AmazeVR is a virtual concert platform for the highest quality VR content creation and mass distribution. We're providing an end-to-end solution for a radical new way to experience immersive music content with our proprietary technologies—from ultra-high-resolution custom cameras to cloud-based creation tools, to intuitive social interactions with friends as avatars. As we vertically integrate distribution channels, artists will reach a broad audience with AmazeVR through offline distribution (Amaze Tour) complying the COVID-19 safety measures and online distribution (Amaze Music app and other media including YouTube, TikTok, and Twitch). AmazeVR was founded in 2015 by the founders and former executives of Kakao, a $27B market cap mobile platform company.

Ring Therapeutics

Series C in 2023
Ring Therapeutics is a multi-product platform company focused on discovering and developing Anellovector therapeutics to unlock the full potential of gene therapy. Founded by Flagship Pioneering, Ring is pioneering the first redosable and targetable gene therapy platform by harnessing the biology of the human commensal virome. The company is expanding the applications of gene therapy beyond gene replacement, enabling a much wider array of modalities and mechanisms to treat previously inaccessible diseases.

Medipixel

Series A in 2021
Medipixel, Inc. develops artificial intelligence based lung cancer diagnostic software solutions and semi autonomous surgical tool control robot systems. Medipixel, Inc. was founded in 2017 and is based in Seoul, South Korea.

Senda Biosciences

Series C in 2022
Senda Biosciences is pioneering the field of Intersystems Biology to create novel treatments for human disease. Intersystems Biology focuses on how molecular connections between botanical, bacterial, and human cells—coevolved over millennia—define health and disease. Senda's Intersytems Biology discovery platform, built using new techniques in machine learning and computational biology, has been able to generate novel, actionable insights into the trillions of interspecies molecular connections in the human body, and harnesses the power of this "pharmacy within us" with novel pharmacological approaches. The power of the Senda platform is illustrated by six preclinical programs in oncology, neurology, chronic disease, and metabolic disease.

Bagelcode

Series C in 2018
Bagelcode, Inc. develops and operates mobile gaming applications. It provides mobile social casinos. The company was founded in 2012 and is based in Seoul, South Korea.

Sonde Health

Series B in 2022
Sonde Health is a digital medicine company developing voice-based technologies to transform the way we monitor and diagnose our mental and physical health.